EP4161528
SAMSETNING RÚXÓLÍTÍNÍBS MEÐ INCB057643 TIL NOTKUNAR VIÐ MEÐFERÐ Á MERGVAXTARÆXLUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.9.2020EP published:
5.11.2025EP application number:
20781202.5
EP translation filed:
18.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
13.9.2040Expiry date:
13.9.2026
Title in English:
COMBINATION OF RUXOLITINIB WITH INCB057643 FOR USE IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMSLanguage of the patent:
English
Timeline
Today
14.9.2020EP application
5.11.2025EP Publication
18.12.2025Translation submitted
14.1.2026Registration published
13.9.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, DE 19803, US
Inventor
Name:
STUBBS, MatthewAddress:
Wilmington, Delaware 19803, US
Name:
LIU, Phillip C.Address:
Wilmington, Delaware 19803, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202063034214 PDate:
3.6.2020Country:
US
Classification
Categories:
A61K 31/538, A61K 31/519, A61P 35/00